Pfizer Inc. (PFE)
27.54
-0.18
(-0.63%)
USD |
NYSE |
Sep 15, 16:00
27.52
-0.02
(-0.09%)
After-Hours: 17:24
Pfizer Price to Book Value : 1.843 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 1.854 |
| September 11, 2026 | 1.854 |
| September 10, 2026 | 1.850 |
| September 09, 2026 | 1.858 |
| September 08, 2026 | 1.859 |
| September 04, 2026 | 1.903 |
| September 03, 2026 | 1.927 |
| September 02, 2026 | 1.941 |
| September 01, 2026 | 1.910 |
| August 31, 2026 | 1.904 |
| August 28, 2026 | 1.870 |
| August 27, 2026 | 1.874 |
| August 26, 2026 | 1.893 |
| August 25, 2026 | 1.911 |
| August 24, 2026 | 1.871 |
| August 21, 2026 | 1.878 |
| August 20, 2026 | 1.859 |
| August 19, 2026 | 1.889 |
| August 18, 2026 | 1.823 |
| August 17, 2026 | 1.798 |
| August 14, 2026 | 1.792 |
| August 13, 2026 | 1.793 |
| August 12, 2026 | 1.760 |
| August 11, 2026 | 1.781 |
| August 10, 2026 | 1.810 |
| Date | Value |
|---|---|
| August 07, 2026 | 1.790 |
| August 06, 2026 | 1.753 |
| August 05, 2026 | 1.727 |
| August 04, 2026 | 1.700 |
| August 03, 2026 | 1.674 |
| July 31, 2026 | 1.673 |
| July 30, 2026 | 1.666 |
| July 29, 2026 | 1.682 |
| July 28, 2026 | 1.689 |
| July 27, 2026 | 1.650 |
| July 24, 2026 | 1.642 |
| July 23, 2026 | 1.673 |
| July 22, 2026 | 1.660 |
| July 21, 2026 | 1.668 |
| July 20, 2026 | 1.656 |
| July 17, 2026 | 1.676 |
| July 16, 2026 | 1.682 |
| July 15, 2026 | 1.660 |
| July 14, 2026 | 1.622 |
| July 13, 2026 | 1.638 |
| July 10, 2026 | 1.617 |
| July 09, 2026 | 1.622 |
| July 08, 2026 | 1.609 |
| July 07, 2026 | 1.610 |
| July 06, 2026 | 1.587 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.565 |
| Eli Lilly & Co. | 31.57 |
| Merck & Co., Inc. | 8.462 |
| Bristol Myers Squibb Co. | 5.835 |
| Viatris, Inc. | 1.348 |
Price to Book Value Related Metrics
| PE Ratio | 36.47 |
| PS Ratio | 2.468 |
| Price to Free Cash Flow | 14.31 |
| Price | 27.54 |
| Earnings Yield | 2.74% |
| Market Cap | 156.98B |
| Operating PE Ratio | 9.288 |
| Normalized PE Ratio | 11.37 |